282 related articles for article (PubMed ID: 23032651)
1. Proton pump inhibitor use and association with spontaneous bacterial peritonitis in patients with cirrhosis and ascites.
Siple JF; Morey JM; Gutman TE; Weinberg KL; Collins PD
Ann Pharmacother; 2012 Oct; 46(10):1413-8. PubMed ID: 23032651
[TBL] [Abstract][Full Text] [Related]
2. Association of proton pump inhibitor therapy with spontaneous bacterial peritonitis in cirrhotic patients with ascites.
Bajaj JS; Zadvornova Y; Heuman DM; Hafeezullah M; Hoffmann RG; Sanyal AJ; Saeian K
Am J Gastroenterol; 2009 May; 104(5):1130-4. PubMed ID: 19337238
[TBL] [Abstract][Full Text] [Related]
3. Proton pump inhibitor use significantly increases the risk of spontaneous bacterial peritonitis in 1965 patients with cirrhosis and ascites: a propensity score matched cohort study.
Min YW; Lim KS; Min BH; Gwak GY; Paik YH; Choi MS; Lee JH; Kim JJ; Koh KC; Paik SW; Yoo BC; Rhee PL
Aliment Pharmacol Ther; 2014 Sep; 40(6):695-704. PubMed ID: 25078671
[TBL] [Abstract][Full Text] [Related]
4. Increased rate of spontaneous bacterial peritonitis among cirrhotic patients receiving pharmacologic acid suppression.
Goel GA; Deshpande A; Lopez R; Hall GS; van Duin D; Carey WD
Clin Gastroenterol Hepatol; 2012 Apr; 10(4):422-7. PubMed ID: 22155557
[TBL] [Abstract][Full Text] [Related]
5. Role of proton pump inhibitors in the occurrence and the prognosis of spontaneous bacterial peritonitis in cirrhotic patients with ascites.
de Vos M; De Vroey B; Garcia BG; Roy C; Kidd F; Henrion J; Deltenre P
Liver Int; 2013 Oct; 33(9):1316-23. PubMed ID: 23730823
[TBL] [Abstract][Full Text] [Related]
6. Clostridium difficile-associated diarrhea and proton pump inhibitor therapy: a meta-analysis.
Janarthanan S; Ditah I; Adler DG; Ehrinpreis MN
Am J Gastroenterol; 2012 Jul; 107(7):1001-10. PubMed ID: 22710578
[TBL] [Abstract][Full Text] [Related]
7. Proton pump inhibitor intake neither predisposes to spontaneous bacterial peritonitis or other infections nor increases mortality in patients with cirrhosis and ascites.
Mandorfer M; Bota S; Schwabl P; Bucsics T; Pfisterer N; Summereder C; Hagmann M; Blacky A; Ferlitsch A; Sieghart W; Trauner M; Peck-Radosavljevic M; Reiberger T
PLoS One; 2014; 9(11):e110503. PubMed ID: 25369194
[TBL] [Abstract][Full Text] [Related]
8. Proton pump inhibitors as a risk factor for hepatic encephalopathy and spontaneous bacterial peritonitis in patients with cirrhosis with ascites.
Dam G; Vilstrup H; Watson H; Jepsen P
Hepatology; 2016 Oct; 64(4):1265-72. PubMed ID: 27474889
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness and safety of proton pump inhibitors in infantile gastroesophageal reflux disease.
Higginbotham TW
Ann Pharmacother; 2010 Mar; 44(3):572-6. PubMed ID: 20124466
[TBL] [Abstract][Full Text] [Related]
10. Proton pump inhibitor use and risk of spontaneous bacterial peritonitis in cirrhotic patients: a systematic review and meta-analysis.
Xu HB; Wang HD; Li CH; Ye S; Dong MS; Xia QJ; Zhang AQ; Pan K; Ge XL; Dong JH
Genet Mol Res; 2015 Jul; 14(3):7490-501. PubMed ID: 26214428
[TBL] [Abstract][Full Text] [Related]
11. Association between proton pump inhibitor use and spontaneous bacterial peritonitis.
Campbell MS; Obstein K; Reddy KR; Yang YX
Dig Dis Sci; 2008 Feb; 53(2):394-8. PubMed ID: 17616817
[TBL] [Abstract][Full Text] [Related]
12. Effect of proton pump inhibitors on the risk and prognosis of infections in patients with cirrhosis and ascites.
Dam G; Vilstrup H; Andersen PK; Bossen L; Watson H; Jepsen P
Liver Int; 2019 Mar; 39(3):514-521. PubMed ID: 30472808
[TBL] [Abstract][Full Text] [Related]
13. Association between acid suppressive therapy and spontaneous bacterial peritonitis in cirrhotic patients with ascites.
Choi EJ; Lee HJ; Kim KO; Lee SH; Eun JR; Jang BI; Kim TN
Scand J Gastroenterol; 2011 May; 46(5):616-20. PubMed ID: 21275825
[TBL] [Abstract][Full Text] [Related]
14. Proton pump inhibitor therapy does not increase the incidence of spontaneous bacterial peritonitis in cirrhosis: a multicenter prospective study.
Terg R; Casciato P; Garbe C; Cartier M; Stieben T; Mendizabal M; Niveyro C; Benavides J; Marino M; Colombato L; Berbara D; Silva M; Salgado P; Barreyro F; Fassio E; Gadano A;
J Hepatol; 2015 May; 62(5):1056-60. PubMed ID: 25481567
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of potential interactions between mycophenolic acid derivatives and proton pump inhibitors.
Gabardi S; Olyaei A
Ann Pharmacother; 2012; 46(7-8):1054-64. PubMed ID: 22811345
[TBL] [Abstract][Full Text] [Related]
16. Use of proton pump inhibitors in the management of gastroesophageal varices: a systematic review.
Lo EA; Wilby KJ; Ensom MH
Ann Pharmacother; 2015 Feb; 49(2):207-19. PubMed ID: 25583938
[TBL] [Abstract][Full Text] [Related]
17. Antibiotic prophylaxis for prevention of spontaneous bacterial peritonitis in patients without gastrointestinal bleeding.
Segarra-Newnham M; Henneman A
Ann Pharmacother; 2010 Dec; 44(12):1946-54. PubMed ID: 21098755
[TBL] [Abstract][Full Text] [Related]
18. Management of ascites in the patient with portal hypertension with emphasis on spontaneous bacterial peritonitis.
Navasa M; Rodés J
Semin Gastrointest Dis; 1997 Oct; 8(4):200-9. PubMed ID: 9360284
[TBL] [Abstract][Full Text] [Related]
19. Long-term prophylaxis of spontaneous bacterial peritonitis in patients with cirrhosis.
Frazee LA; Marinos AE; Rybarczyk AM; Fulton SA
Ann Pharmacother; 2005 May; 39(5):908-12. PubMed ID: 15769829
[TBL] [Abstract][Full Text] [Related]
20. Proton pump inhibitors use and risk of developing spontaneous bacterial peritonitis in cirrhotic patients: A systematic review and meta-analysis.
Alhumaid S; Al Mutair A; Al Alawi Z; Zaidi ARZ; Rabaan AA; Elhazmi A; Al-Omari A
Gut Pathog; 2021 Mar; 13(1):17. PubMed ID: 33741033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
